市场调查报告书
商品编码
1494905
到 2030 年 D-胺基酸市场预测:按类型、製造方法、形式、应用、最终用户和地区进行的全球分析D-Amino Acid Market Forecasts to 2030 - Global Analysis By Type, Production Method, Form, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2024 年全球 D-氨基酸市场规模为 1.869 亿美元,预计在预测期内将以 5.2% 的复合年增长率增长,并在 2030 年达到 2.547 亿美元。
D-胺基酸是天然存在的L-胺基酸的镜像形式,并以其分子结构的D-构型来区分。 L-胺基酸主要存在于蛋白质中,而 D-胺基酸在各种生物过程中具有独特的作用,并用于药物、食品添加剂和工业应用。 D-胺基酸在药物稳定性和活性方面具有独特的优势,有助于其在生物技术和医学中的专业应用。
根据欧洲製药协会联合会(EFPIA)统计,2020年欧洲药品总产量为3,100亿欧元(约3,540.8076亿美元),较2019年成长5.7%。
增加食品和饲料添加剂的使用
食品和饲料添加剂对 D-氨基酸的需求不断增加是市场的关键驱动因素。 D-胺基酸用作风味增强剂、营养食品和饲料添加剂,以改善动物健康和生长。消费者对天然和健康食品的偏好不断提高,加上对动物性产品的需求不断增长,正在推动 D-氨基酸在这些应用中的使用,从而推动市场成长。
生产成本高
D-胺基酸的高生产成本是市场的主要限制因素。製造过程涉及复杂的酶反应和精製步骤,这导致成本上升。此外,原材料供应有限以及对专业设备和熟练劳动力的需求进一步增加了生产成本。这些高成本可能会限制 D-氨基酸在价格敏感的应用和市场中的采用。
生物技术的进步
基因工程、酵素技术和发酵製程的进步使得 D-胺基酸的生产更有效率且更具成本效益。这些技术进步可以优化微生物菌株,提高产量和纯度,并探索替代原料。生物技术创新有助于克服生产挑战并扩大 D-氨基酸的应用范围。
来自合成替代品的竞争
D-胺基酸市场面临合成替代品的威胁。模仿 D-胺基酸特性和功能的合成化合物正在成为有竞争力的替代品。这些合成替代品可能具有生产成本较低、品质稳定和易于扩充性等优点。合成替代品的供应和采用的增加可能会影响对天然 D-氨基酸的需求,并对市场成长构成威胁。
COVID-19 大流行对 D-氨基酸市场产生了各种影响。食品和饲料行业对 D-氨基酸的需求因供应链挑战和消费者支出减少而受到干扰,同时人们对含有 D-氨基酸的膳食食品等健康和保健产品的兴趣也有所增加。然而,疫情期间经济放缓以及製造业和贸易活动受到限制,为市场成长带来了挑战。
D-丙胺酸部分预计在预测期内将是最大的
在预测期内,D-丙胺酸部分预计将成为 D-胺基酸市场最大的部分。这是由于其在各行业的广泛应用。 D-丙胺酸广泛应用于食品工业中作为增味剂、改善动物营养的饲料添加剂,以及製药工业中作为胜胜肽合成的基础材料。 D-丙胺酸因其多功能性和这些关键应用领域不断增长的需求而占据市场主导地位。
预计食品产业在预测期内复合年增长率最高
预计在预测期内,食品领域将在 D-胺基酸市场中表现出最高的复合年增长率。消费者健康意识的提高,加上与文明病盛行率的上升,正在推动对营养食品的需求。 D-胺基酸越来越多地被纳入营养食品中,因为它们具有潜在的健康益处,包括改善认知功能和肌肉恢復。食品产业的高成长潜力以及D-胺基酸在该领域的不断扩大的应用预计将支持该领域的快速成长。
预计北美将占据 D-氨基酸市场的最大份额。该地区的优势可归因于多种因素,包括成熟的食品和製药行业、消费者对健康和营养的高度认识以及支持性的法规环境。尤其是美国,受机能性食品、营养食品和先进药物配方需求的推动,成为 D-氨基酸的主要市场。该地区强大的研发能力和生物技术的技术进步也促成了其在D-氨基酸市场的主导地位。
预计亚太地区在预测期内 D-胺基酸市场的复合年增长率最高。该地区的成长是由可支配收入增加、饮食偏好变化以及消费者健康意识增强等因素所推动的。中国、日本和印度等国家由于人口众多、食品和饲料工业不断扩大以及对食品的需求不断增加,对市场成长做出了重大贡献。该地区研发投资的增加,加上先进生物技术的采用,预计将进一步推动亚太地区 D-氨基酸市场的快速成长。
According to Stratistics MRC, the Global D-Amino Acid Market is accounted for $186.9 million in 2024 and is expected to reach $254.7 million by 2030 growing at a CAGR of 5.2% during the forecast period. D-amino acids are the mirror-image forms of naturally occurring L-amino acids, distinguished by their D-configuration in the molecular structure. While L-amino acids are predominantly found in proteins, D-amino acids have unique roles in various biological processes and are utilized in pharmaceuticals, food additives, and industrial applications. They offer distinct advantages in drug stability and activity, contributing to their specialized use in biotechnology and medicine.
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2020, the total production of pharmaceuticals in Europe was EURO 310,000 million (approximately US$354,080.76 million), an increase of 5.7% over 2019
Increasing use in food and feed additives
The growing demand for D-amino acids in food and feed additives is a significant driver for the market. D-amino acids are used as flavor enhancers, nutritional supplements, and feed additives to improve animal health and growth. The increasing consumer preference for natural and healthy food products, coupled with the rising demand for animal-based products, is fueling the use of D-amino acids in these applications, thereby driving market growth.
High production costs
The high production costs associated with D-amino acids are a major restraint for the market. The manufacturing process involves complex enzymatic reactions and purification steps, which contribute to the elevated costs. Additionally, the limited availability of raw materials and the need for specialized equipment and skilled labor further increase production expenses. These high costs can limit the adoption of D-amino acids in price-sensitive applications and markets.
Advancements in biotechnology
Developments in genetic engineering, enzyme technology, and fermentation processes are enabling more efficient and cost-effective production of D-amino acids. These technological advancements allow for the optimization of microbial strains, improvement of yield and purity, and the exploration of alternative raw materials. Biotechnology innovations can help overcome production challenges and expand the application scope of D-amino acids.
Competition from synthetic alternatives
The D-amino acid market faces a threat from synthetic alternatives. Synthetic compounds that mimic the properties and functions of D-amino acids are emerging as competitive substitutes. These synthetic alternatives may offer advantages such as lower production costs, consistent quality, and easier scalability. The increasing availability and adoption of synthetic alternatives can potentially impact the demand for natural D-amino acids and pose a threat to market growth.
The Covid-19 pandemic has had a mixed impact on the D-amino acid market. While the demand for D-amino acids in the food and feed industries experienced some disruptions due to supply chain challenges and reduced consumer spending, the market also witnessed increased interest in health and wellness products, including nutritional supplements containing D-amino acids. However, the pandemic-induced economic slowdown and restrictions on manufacturing and trade activities posed challenges for market growth during this period.
The D-Alanine segment is expected to be the largest during the forecast period
The D-Alanine segment is projected to be the largest segment in the D-amino acid market during the forecast period. This can be attributed to its wide range of applications in various industries. D-Alanine is extensively used as a flavor enhancer in the food industry, as a feed additive to improve animal nutrition, and as a building block for peptide synthesis in the pharmaceutical industry. The versatility and increasing demand for D-Alanine across these key application areas contribute to its dominant market position.
The nutritional supplements segment is expected to have the highest CAGR during the forecast period
The nutritional supplements segment is anticipated to exhibit the highest CAGR in the D-amino acid market during the forecast period. The growing consumer awareness about health and wellness, coupled with the rising prevalence of lifestyle-related diseases, is driving the demand for nutritional supplements. D-amino acids are increasingly being incorporated into dietary supplements due to their potential health benefits, such as improved cognitive function and muscle recovery. The high growth potential of the nutritional supplements industry and the expanding application of D-amino acids in this segment are expected to fuel its rapid growth.
North America is expected to hold the largest share in the D-amino acid market. The region's dominance can be attributed to several factors, including the presence of well-established food and pharmaceutical industries, high consumer awareness about health and nutrition, and supportive regulatory environment. The United States, in particular, is a major market for D-amino acids, driven by the demand for functional foods, dietary supplements, and advanced pharmaceutical formulations. The region's strong research and development capabilities and technological advancements in biotechnology also contribute to its leading position in the D-amino acid market.
The Asia Pacific region is projected to witness the highest CAGR in the D-amino acid market during the forecast period. The region's growth can be attributed to factors such as rising disposable incomes, changing dietary preferences, and increasing health consciousness among consumers. Countries like China, Japan, and India are major contributors to the market's growth, driven by their large populations, expanding food and feed industries, and growing demand for nutritional supplements. The region's increasing investments in research and development, coupled with the adoption of advanced biotechnology techniques, are expected to further fuel the rapid growth of the D-amino acid market in Asia Pacific.
Key players in the market
Some of the key players in D-Amino Acid Market include Ajinomoto Co., Inc., Evonik Industries AG, Sigma-Aldrich (Merck KGaA), Kyowa Hakko Bio Co., Ltd., Thermo Fisher Scientific Inc., Central Drug House (P) Ltd., Amino GmbH, TCI Chemicals (India) Pvt. Ltd., Tokyo Chemical Industry Co., Ltd., PepTech Corporation, Wuhan Amino Acid Bio-Chemical Co., Ltd., Chemical Dynamics Corporation, AnaSpec, Inc., LifeSpan BioSciences, Inc., CBL Biotech Pvt. Ltd., Enzo Life Sciences, Inc., Bio-Synthesis Inc., Zhejiang NHU Company Ltd., Santa Cruz Biotechnology, Inc., and Creative Peptides.
In April 2024, Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra(TM) CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and therefore, their move into commercial production.
In January 2024, Qatar Free Zones Authority (QFZ) and Evonik, a leading specialty Chemicals Company headquartered in Germany, have signed a Memorandum of Understanding (MoU) at the sidelines of the Qatar Economic Forum. The common aim is to explore specific investment opportunities focused on sustainable solutions for energy transition.
In December 2023, Ajinomoto Co., Inc. announced that it completed procedures on December 21, 2023 (local time) for acquisition of all equities of Forge Biologics Holdings, LLC ("Forge") through its consolidated subsidiary Ajinomoto North America Holdings, Inc., in line with its press release "Ajinomoto Group Acquires Forge Biologics, a US-Based Gene Therapy CDMO for Approximately JPY 82.8 Billion".
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.